RxDoctor Payments Data

Andrew Bartlett, MD

Internal Medicine · Jackson, MSNPI 1477932770

Payments from drug & device makers

$2,789in general payments, 2019–2025

Across 144 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$853
  • Lilly USA, LLC$310
  • Abbott$260
  • Pfizer$258
  • Novo Nordisk$197
  • GSK$165
  • plus $746 from 18 others

What the payments were for

  • Food & beverage$2,789100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,789 in reported general payments places this provider in the 80th percentile of 846 internal medicine providers in Mississippi.

See all internal medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$111,412
Medicare patients
356
Services billed
2,349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban229$219,183
OzempicSemaglutide169$180,036
EntrestoSacubitril/Valsartan159$154,721
LinzessLinaclotide162$147,024
JardianceEmpagliflozin177$144,405
TrulicityDulaglutide106$104,485
FarxigaDapagliflozin Propanediol136$104,016
JanuviaSitagliptin Phosphate84$68,817
TradjentaLinagliptin81$62,375
XareltoRivaroxaban52$56,151
Trelegy ElliptaFluticasone/Umeclidin/Vilanter67$50,767
RybelsusSemaglutide24$39,382
MyrbetriqMirabegron53$34,108
MitigareColchicine36$17,065
Lantus SolostarInsulin Glargine,hum.Rec.Anlog133$16,422

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Glyxambi, Synjardy Xr$58$225,951290 claims
Novo NordiskOzempic, Rybelsus$197$219,418193 claims
PfizerEliquis$258$219,183229 claims
NovartisEntresto$84$154,721159 claims
AbbVieLinzess$110$147,024162 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere, Brilinta$853$139,335228 claims
Lilly USA, LLCTrulicity$310$104,485106 claims
Johnson & JohnsonXarelto$99$56,15152 claims
GSKTrelegy Ellipta, Breo Ellipta$165$54,69578 claims
Astellas Pharma US IncMyrbetriq$17$34,10853 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 846 internal medicine providers in Mississippi.

Other internal medicine in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →